|
인쇄하기
취소
|
CJ and Pfizer Korea jointly to promote Campto.
Published: 2005-06-07 06:56:00
Updated: 2005-06-07 06:56:00
CJ pharmaceutical division and Pfizer Korea have made a joint marketing promotion agreement for Campto (Irinotecan Hcl), a anti-cancer drug for the metastasis colon cancer starting from June 1, which may provide a chance for the both parties to create a synergic effects in the marketing and selling of Campto.
The two parties have adopted a model called "Double Hitting" of allocating their s...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.